as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹370.85
Change
-2.2 (-0.59%)
Open
₹374.9
Prev. Close
₹373.05
Day High
₹374.9
Day Low
₹369.0
Volume Analysis
Traded
12,212
Delivered
7,855
Delivery %
64.32%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •High debt-to-equity ratio (1.03)
- •Promoter holding is falling
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹380.06 | ₹377.48 | ₹374.16 | ₹371.58 | ₹368.26 | ₹365.68 | ₹362.36 |
| Fibonacci | ₹377.48 | ₹375.23 | ₹373.83 | ₹371.58 | ₹369.33 | ₹367.93 | ₹365.68 |
| Camarilla | ₹372.47 | ₹371.93 | ₹371.39 | ₹371.58 | ₹370.31 | ₹369.77 | ₹369.23 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+36.74%
1 Week
-3.74%
1 Month
-12.15%
3 Months
-27.55%
6 Months
+14.94%
1 Year
+50.66%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹177.54
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
14.31%
Net margin 19.31% × asset turnover 0.3x × equity multiplier 2.47x
Company Overview
Sector
Chemicals
Market Cap
₹1,209 Cr
P/E (TTM)
28.5
ROE
10.1%
Book Value
₹89.4
Face Value
₹1.0
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Indo Borax & Chemical Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 52/100. The strongest factor is Cash Flow (75/100), while Growth (20/100) is the weakest area to weigh before deciding. Notably: High debt-to-equity ratio (1.03); promoter holding is falling.
TopFund Score — Fundamentals Quality
52/100 — AverageData confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Debtor days have improved from 25.5 to 17.6 days.
- −The company has delivered a poor sales growth of 8.37% over past five years.
- −Company has a low return on equity of 12.2% over last 3 years.
- −Company might be capitalizing the interest cost
- −Promoters have pledged 100% of their holding.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
H1FY27 operating income rose 16% to Rs 129.29 crore; completed 64.26% Kronox acquisition and named Suresh Kalra MD/CEO.
Copies of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026 published in Free Press Journal and Navshakti
Board approved Q2 FY27 results; acquired 64.26% of Kronox Lab Sciences on 29 Sep 2026.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 47 | 44 | 45 | 50 | 38 | 38 | 50 | 54 | 58 | 41 | 63 | 70 | 59 |
| Expenses + | 37 | 35 | 34 | 33 | 29 | 27 | 40 | 41 | 47 | 32 | 50 | 51 | 57 |
| Operating Profit | 10 | 9 | 12 | 16 | 9 | 10 | 10 | 12 | 11 | 9 | 13 | 20 | 1 |
| OPM % | 21.71% | 20.84% | 25.45% | 33.06% | 24.19% | 26.85% | 20.35% | 22.79% | 18.15% | 21.01% | 20.35% | 28.14% | 2.51% |
| Other Income + | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 13 | 4 | 5 | 3 | 8 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Profit before tax | 12 | 11 | 14 | 19 | 13 | 14 | 13 | 14 | 23 | 12 | 17 | 22 | 8 |
| Tax % | 27.36% | 27.49% | 20.22% | 27.03% | 29.25% | 33.75% | 19.87% | 29.02% | 27.88% | 23.72% | 16.68% | 26.09% | 39.2% |
| Net Profit + | 9 | 8 | 11 | 14 | 9 | 9 | 10 | 10 | 16 | 9 | 15 | 16 | 5 |
| EPS in Rs | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 5 | 3 | 5 | 5 | 1 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | -24 | -20 | -19 | -9 | -19 | -15 | 10 | 8 | 53 | 9 | 26 | 31 | 2 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 87 | 70 | 67 | 101 | 128 | 115 | 144 | 176 | 225 | 191 | 175 | 215 | 233 |
| Expenses + | 69 | 57 | 56 | 83 | 108 | 97 | 100 | 128 | 163 | 149 | 129 | 171 | 191 |
| Operating Profit | 19 | 12 | 10 | 18 | 20 | 19 | 44 | 48 | 62 | 43 | 46 | 44 | 43 |
| OPM % | 21.0% | 18.0% | 15.0% | 17.0% | 16.0% | 16.0% | 31.0% | 27.0% | 28.0% | 22.0% | 26.0% | 21.0% | 18.0% |
| Other Income + | 3 | 3 | 3 | 4 | 6 | 5 | 4 | 3 | 9 | 12 | 16 | 25 | 20 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 2 |
| Profit before tax | 20 | 14 | 12 | 20 | 24 | 22 | 47 | 50 | 69 | 52 | 59 | 67 | 59 |
| Tax % | 32.0% | 32.0% | 31.0% | 34.0% | 28.0% | 24.0% | 26.0% | 27.0% | 26.0% | 25.0% | 28.0% | 24.0% | — |
| Net Profit + | 14 | 9 | 8 | 13 | 18 | 17 | 34 | 36 | 51 | 39 | 43 | 50 | 45 |
| EPS in Rs | 4 | 3 | 2 | 4 | 5 | 5 | 11 | 11 | 16 | 12 | 13 | 16 | 14 |
| Dividend Payout % | 4.0% | 5.0% | 6.0% | 4.0% | 3.0% | 4.0% | 9.0% | 1.0% | 6.0% | 8.0% | 8.0% | 6.0% | — |
| Sales growth | 14 | -20 | -4 | 51 | 27 | -10 | 25 | 22 | 28 | -15 | -8 | 23 | 17 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 75 | 84 | 91 | 101 | 118 | 135 | 170 | 204 | 252 | 290 | 332 | 383 | 284 |
| Borrowings + | 5 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 296 |
| Other Liabilities + | 9 | 8 | 10 | 12 | 11 | 10 | 17 | 14 | 20 | 18 | 21 | 17 | 126 |
| Total Liabilities | 92 | 97 | 106 | 117 | 132 | 149 | 190 | 222 | 275 | 311 | 357 | 405 | 708 |
| Fixed Assets + | 11 | 21 | 52 | 51 | 50 | 46 | 89 | 91 | 96 | 99 | 101 | 48 | 264 |
| CWIP | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 |
| Investments | 14 | 32 | 23 | 20 | 37 | 18 | 30 | 4 | 9 | 43 | 57 | 209 | 14 |
| Other Assets + | 65 | 43 | 29 | 45 | 44 | 84 | 70 | 126 | 169 | 169 | 198 | 147 | 427 |
| Total Assets | 92 | 97 | 106 | 117 | 132 | 149 | 190 | 222 | 275 | 311 | 357 | 405 | 708 |
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 0 | 18 | 21 | 1 | 15 | 13 | 16 | 11 | 60 | 69 | -104 | 87 |
| Cash from Investing Activity + | 13 | -26 | -24 | 5 | -16 | 26 | -54 | 26 | -8 | -30 | -7 | -77 |
| Cash from Financing Activity + | -1 | -4 | -1 | -2 | -1 | -1 | -1 | -3 | -3 | -3 | -3 | -3 |
| Net Cash Flow | 12 | -12 | -4 | 5 | -2 | 38 | -39 | 34 | 49 | 36 | -115 | 7 |
| Free Cash Flow | -10 | 7 | 19 | 1 | 14 | 13 | 15 | 11 | 57 | 65 | -111 | 106 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 38 | 186 | 226 | 37 | 111 | 100 | 61 | 54 | 123 | 197 | -194 | 242 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 47.89% | 49.09% | 49.15% | 49.14% | 49.2% | 49.16% | 49.16% | 48.67% | 48.96% | 66.56% | 61.43% | 61.45% |
| Promoters | 52.07% | 50.8% | 50.79% | 50.79% | 50.79% | 50.79% | 50.79% | 50.79% | 50.79% | 30.8% | 38.41% | 38.41% |
| FII | 0.03% | 0.1% | 0.0% | 0.06% | 0.01% | 0.02% | 0.02% | 0.53% | 0.23% | 0.45% | 0.13% | 0.1% |
| DII | 0.0% | 0.0% | 0.06% | 0.0% | 0.0% | 0.01% | 0.02% | 0.02% | 0.02% | 2.19% | 0.04% | 0.04% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Indo Borax & Chemical Ltd (this stock) | 1,209 | 28.5 | 4.21 | 10.1% |
| Platinum Industries Ltd | 1,208 | 26.0 | 2.62 | 12.7% |
| Astec Lifesciences Ltd | 1,219 | — | 3.65 | -25.2% |
| Ultramarine & Pigments L | 1,192 | 11.9 | 1.35 | 8.59% |
| Excel Industries Ltd | 1,246 | 15.8 | 0.6 | 4.62% |
| Spic Ltd | 1,246 | 6.53 | 0.86 | 15.0% |
| India Pesticides Limited | 1,333 | 14.1 | 1.28 | 12.5% |
Which Mutual Funds Hold Indo Borax & Chemical Ltd?
Frequently Asked Questions about Indo Borax & Chemical Ltd
Indo Borax & Chemical Ltd (INDOBORAX) closed at ₹370.85 on NSE on 19 November 2026, down 2.2 (0.59%) from the previous close.
Indo Borax & Chemical Ltd trades on the NSE (National Stock Exchange of India) under the symbol INDOBORAX.
Indo Borax & Chemical Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 28.5.
Indo Borax & Chemical Ltd has a dividend yield of 2.66%.
Indo Borax & Chemical Ltd's 52-week high is ₹543.0 and its 52-week low is ₹230.0.
Indo Borax & Chemical Ltd has a market capitalisation of ₹1,209 crore.
Indo Borax & Chemical Ltd has a TopFund Quality Score of 52/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Indo Borax & Chemical Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.